# FDA Inspection 1252246 - Zhejiang Starry Pharmaceutical Co. Ltd. - September 06, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-starry-pharmaceutical-co-ltd/bf510f18-1054-4b1a-b5de-4fe0e33b8e23
Source feed: FDA_Inspections

> FDA Inspection 1252246 for Zhejiang Starry Pharmaceutical Co. Ltd. on September 06, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252246
- Company Name: Zhejiang Starry Pharmaceutical Co. Ltd.
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252246 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/zhejiang-starry-pharmaceutical-co-ltd/33d3b5bd-2de1-40a5-a9a1-d144e5b64c07)
- [FDA Inspection 1098549 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/zhejiang-starry-pharmaceutical-co-ltd/489fdd5b-31c0-4d9f-8ef2-36ac1fade7cd)

Company: https://www.keypedia.com/companies/zhejiang-starry-pharmaceutical-co-ltd/eb59f9e2-22be-43f3-be3c-de1dbf375209

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c